Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

LGBTQ+ rights in Venezuela have suffered under an oppressive government and widespread poverty.

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

Over 16,000 individuals living with HIV in Florida might lose access to their essential medications starting March 1 due to a ...

Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...